NCT04976023View on ClinicalTrials.gov

The Effects of Using Yupingfeng Powder with Variation for the Treatment of Allergic Rhinitis

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

April 12, 2022

Primary Completion Date

June 20, 2023

Study Completion Date

June 20, 2023

Conditions
Allergic Rhinitis
Interventions
DRUG

Yupingfeng Powder granules

14.5 5 g twice daily for 8 weeks

OTHER

Placebo

14.5 5 g twice daily for 8 weeks

Trial Locations (1)

Unknown

The Chinese University of Hong Kong, Shatin

All Listed Sponsors
lead

Prof. Lin Zhixiu

OTHER